Jubilant Life Sciences repays FCCBs worth $202 million

23 May 2011 Evaluate

Jubilant Life Sciences, an integrated pharmaceutical industry player and the largest custom research and manufacturing services company in India, has repaid $202 million on account of outstanding Foreign Currency Convertible Bonds (FCCBs) including yield-to-maturity (YTM) of $60 million. Following the repayment, no more FCCBs are outstanding in the books.

The company has repaid all the outstanding FCCBs on time, as per schedule, in line with the terms and conditions of the FCCB instruments, showing its commitment to meet its obligation on time and demonstrating its financial strength.

Jubilant Life Sciences is an integrated pharma and life sciences company offering Life Sciences products and services to the global life sciences industry. It is the largest custom research and manufacturing services company and a leading integrated drug discovery and development solutions company out of India.

Jubilant Pharmova Share Price

1076.50 7.30 (0.68%)
05-Dec-2025 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.15
Dr. Reddys Lab 1275.50
Cipla 1521.80
Zydus Lifesciences 931.80
Lupin 2100.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×